• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

糖尿病患者心血管-肾脏-代谢综合征的健康社会决定因素

Social Determinants of Health for Cardiovascular-Kidney-Metabolic Syndrome Among Patients With Diabetes.

作者信息

Belay Kibret Enyew, Feleke Yeweyenhareg, Alemneh Theodros Aberra, Haile Asteway Mulat, Abebe Dawit Girma

机构信息

Department of Internal Medicine, Endocrinology and Metabolism Unit, Addis Ababa University, Addis Ababa 1000, Ethiopia.

Department of Internal Medicine, Addis Ababa University, Addis Ababa 1000, Ethiopia.

出版信息

J Endocr Soc. 2024 Nov 22;9(1):bvae208. doi: 10.1210/jendso/bvae208. eCollection 2024 Nov 26.

DOI:10.1210/jendso/bvae208
PMID:39669651
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11635457/
Abstract

CONTEXT

syndrome is a recently introduced term that is a complex disease consisting of cardiovascular disease, renal disease, obesity, and diabetes. The association of social determinants of health (SDOH) with CKM syndrome is not fully known.

OBJECTIVE

We aimed to assess SDOH affecting CKM syndrome among adult patients with diabetes at follow-up at a tertiary hospital in Ethiopia.

METHODS

A cross-sectional hospital-based study was used. Data were collected using a Kobo toolbox and entered into SPSS version 29 for further analysis.

RESULTS

A total of 422 adult patients with diabetes were included in this study. The mean ± SD age of the patients was 54.14 ± 13.74 years. Fifty-two percent of the patients were male. In this study, 52.4% had cardiovascular kidney metabolic syndrome. Male patients (AOR: 1.73; 95% CI, 1.01-2.94), lost to follow-up for more than a year due to lack of money (AOR: 2.69; 95% CI, 1.01-7.22), missed an appointment due to lack of transportation in the past 1 year (AOR: 2.98; 95% CI, 1.21-7.33), were patients with disability (AOR: 1.97; 95% CI, 1.12-3.48), had hypertension (AOR: 3.12; 95% CI, 1.85-5.28), had obesity (AOR: 2.27, 95% CI, 1.17, 4.40), and were in retirement (AOR: 2.12; 95% CI, 1.04-4.30) these being more significantly associated with CKM syndrome.

CONCLUSION

More than half of patients had CKM syndrome. More attention should be given to SDOH, including male sex, financial constraints, transportation issues, disability, and retirement.

摘要

背景

综合征是一个最近引入的术语,指的是一种由心血管疾病、肾脏疾病、肥胖症和糖尿病组成的复杂疾病。健康的社会决定因素(SDOH)与CKM综合征之间的关联尚不完全清楚。

目的

我们旨在评估在埃塞俄比亚一家三级医院接受随访的成年糖尿病患者中影响CKM综合征的SDOH。

方法

采用基于医院的横断面研究。使用Kobo工具箱收集数据,并录入SPSS 29版本进行进一步分析。

结果

本研究共纳入422例成年糖尿病患者。患者的平均年龄±标准差为54.14±13.74岁。52%的患者为男性。在本研究中,52.4%的患者患有心血管肾脏代谢综合征。男性患者(调整后比值比[AOR]:1.73;95%置信区间[CI],1.01-2.94)、因缺钱失访超过一年的患者(AOR:2.69;95%CI,1.01-7.22)、在过去1年因交通不便错过预约的患者(AOR:2.98;95%CI,1.21-7.33)、残疾患者(AOR:1.97;95%CI,1.12-3.48)、患有高血压的患者(AOR:3.12;95%CI,1.85-5.28)、患有肥胖症的患者(AOR:2.27,95%CI,1.17,4.40)以及退休患者(AOR:2.12;95%CI,1.04-4.30)与CKM综合征的关联更为显著。

结论

超过一半的患者患有CKM综合征。应更加关注SDOH,包括男性、经济限制、交通问题、残疾和退休等因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f5c/11635457/051651187fba/bvae208f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f5c/11635457/051651187fba/bvae208f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f5c/11635457/051651187fba/bvae208f1.jpg

相似文献

1
Social Determinants of Health for Cardiovascular-Kidney-Metabolic Syndrome Among Patients With Diabetes.糖尿病患者心血管-肾脏-代谢综合征的健康社会决定因素
J Endocr Soc. 2024 Nov 22;9(1):bvae208. doi: 10.1210/jendso/bvae208. eCollection 2024 Nov 26.
2
Prevalence of Cardiovascular-Kidney-Metabolic Syndrome Stages by Social Determinants of Health.按健康社会决定因素划分的心血管-肾脏-代谢综合征各阶段的流行率。
JAMA Netw Open. 2024 Nov 4;7(11):e2445309. doi: 10.1001/jamanetworkopen.2024.45309.
3
The prognostic significance of stress hyperglycemia ratio in evaluating all-cause and cardiovascular mortality risk among individuals across stages 0-3 of cardiovascular-kidney-metabolic syndrome: evidence from two cohort studies.应激性高血糖比值在评估心血管-肾脏-代谢综合征0至3期个体全因和心血管死亡风险中的预后意义:两项队列研究的证据
Cardiovasc Diabetol. 2025 Mar 24;24(1):137. doi: 10.1186/s12933-025-02689-6.
4
Impact of Cardiovascular-Kidney-Metabolic Syndrome Staging on Myocardial Infarction Outcomes: A Retrospective Analysis of 2.7 Million Patients.心血管-肾脏-代谢综合征分期对心肌梗死预后的影响:对270万患者的回顾性分析
Diseases. 2025 Mar 27;13(4):97. doi: 10.3390/diseases13040097.
5
Gender Disparities in the Association Between Educational Attainment and Cardiovascular-Kidney-Metabolic Syndrome: Cross-Sectional Study.教育程度与心血管-肾脏-代谢综合征关联中的性别差异:横断面研究。
JMIR Public Health Surveill. 2024 Aug 23;10:e57920. doi: 10.2196/57920.
6
Associations of cardiovascular-kidney-metabolic syndrome stages with premature mortality and the role of social determinants of health.心血管-肾脏-代谢综合征各阶段与过早死亡的关联以及健康的社会决定因素的作用。
J Nutr Health Aging. 2025 Apr;29(4):100504. doi: 10.1016/j.jnha.2025.100504. Epub 2025 Feb 13.
7
An overview of cardiovascular-kidney-metabolic syndrome.心血管-肾脏-代谢综合征概述
Am J Manag Care. 2024 Dec;30(10 Suppl):S181-S188. doi: 10.37765/ajmc.2024.89670.
8
Metabolic syndrome in patients with type 2 diabetes mellitus at Adama Hospital Medical College, Ethiopia: a hospital-based cross-sectional study.埃塞俄比亚阿达马医院医学院2型糖尿病患者的代谢综合征:一项基于医院的横断面研究。
Front Clin Diabetes Healthc. 2023 Jun 15;4:1165015. doi: 10.3389/fcdhc.2023.1165015. eCollection 2023.
9
Social Determinants of Health in the Development of Cardiovascular-kidney-metabolic Syndrome.心血管-肾脏-代谢综合征发展过程中的健康社会决定因素
Rev Cardiovasc Med. 2025 Mar 7;26(3):26580. doi: 10.31083/RCM26580. eCollection 2025 Mar.
10
Social Risk Profile and Cardiovascular-Kidney-Metabolic Syndrome in US Adults.美国成年人的社会风险概况与心血管-肾脏-代谢综合征。
J Am Heart Assoc. 2024 Aug 20;13(16):e034996. doi: 10.1161/JAHA.124.034996. Epub 2024 Aug 13.

本文引用的文献

1
Finerenone in heart failure and chronic kidney disease with type 2 diabetes: FINE-HEART pooled analysis of cardiovascular, kidney and mortality outcomes.非奈利酮用于伴2型糖尿病的心力衰竭和慢性肾脏病:FINE-HEART心血管、肾脏及死亡率结局的汇总分析
Nat Med. 2024 Dec;30(12):3758-3764. doi: 10.1038/s41591-024-03264-4. Epub 2024 Sep 1.
2
Cardiovascular and non-renal complications of chronic kidney disease: Managing risk.慢性肾脏病的心血管和非肾脏并发症:管理风险。
Diabetes Obes Metab. 2024 Nov;26 Suppl 6:13-21. doi: 10.1111/dom.15747. Epub 2024 Jul 9.
3
Effects of semaglutide with and without concomitant SGLT2 inhibitor use in participants with type 2 diabetes and chronic kidney disease in the FLOW trial.
在 FLOW 试验中,有 2 型糖尿病和慢性肾病的参与者使用和不使用 SGLT2 抑制剂的司美格鲁肽的影响。
Nat Med. 2024 Oct;30(10):2849-2856. doi: 10.1038/s41591-024-03133-0. Epub 2024 Jun 24.
4
APOL1 Kidney Risk Variants and Long-Term Kidney Function in Healthy Middle-Aged Black Individuals: The Atherosclerosis Risk in Communities (ARIC) Study.载脂蛋白L1肾脏风险变异与健康中年黑人个体的长期肾功能:社区动脉粥样硬化风险(ARIC)研究
Kidney Med. 2024 Apr 17;6(6):100828. doi: 10.1016/j.xkme.2024.100828. eCollection 2024 Jun.
5
Prevalence of Cardiovascular-Kidney-Metabolic Syndrome Stages in US Adults, 2011-2020.2011 - 2020年美国成年人心血管 - 肾脏 - 代谢综合征各阶段的患病率
JAMA. 2024 Jun 4;331(21):1858-1860. doi: 10.1001/jama.2024.6892.
6
Effects of Sodium-Glucose Cotransporter 2 Inhibitors on Cause-Specific Cardiovascular Death in Patients with CKD: A Meta-Analysis of CKD Progression Trials.钠-葡萄糖协同转运蛋白2抑制剂对慢性肾脏病患者特定病因心血管死亡的影响:慢性肾脏病进展试验的荟萃分析
Clin J Am Soc Nephrol. 2024 Sep 1;19(9):1180-1182. doi: 10.2215/CJN.0000000000000470. Epub 2024 Apr 16.
7
Effects of finerenone and glucagon-like peptide 1 receptor agonists on cardiovascular and renal outcomes in type 2 diabetes mellitus: a systematic review and meta-analysis.非奈利酮和胰高血糖素样肽-1受体激动剂对2型糖尿病患者心血管和肾脏结局的影响:一项系统评价和荟萃分析
Diabetol Metab Syndr. 2024 Jan 11;16(1):14. doi: 10.1186/s13098-023-01251-2.
8
5. Facilitating Positive Health Behaviors and Well-being to Improve Health Outcomes: Standards of Care in Diabetes-2024.5. 促进积极的健康行为与福祉以改善健康结果:2024年糖尿病护理标准
Diabetes Care. 2024 Jan 1;47(Suppl 1):S77-S110. doi: 10.2337/dc24-S005.
9
11. Chronic Kidney Disease and Risk Management: Standards of Care in Diabetes-2024.11. 慢性肾脏病与风险管理:2024年糖尿病护理标准
Diabetes Care. 2024 Jan 1;47(Suppl 1):S219-S230. doi: 10.2337/dc24-S011.
10
Are physically disabled people at high risk of coronary heart disease among disabled population - Evidence from 7.5-year retrospective cohort study.在残疾人群体中,身体残疾者患冠心病的风险高吗?——来自7.5年回顾性队列研究的证据
Ann Epidemiol. 2024 Feb;90:42-48. doi: 10.1016/j.annepidem.2023.11.001. Epub 2023 Nov 4.